trial · primary record
JNJ-95597528
Dermatitis, Atopic
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 189 |
| Primary completion | 2028-02-10 |
| Primary endpoint | Proportion of Participants with Eczema Area and Severity Index (EASI) 75 Response at Week 12 |
| Registry ID | NCT07230860 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:05.663Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07230860
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Jnj-95597528 · compound